CILA Therapeutics
PrivateLast Round
Grant
Aug 11, 2025
Total Funding Raised
$379,948
Momentum Score
50 /100
Company Overview
CILA Therapeutics is a biotechnology company that develops inhaled therapies for obstructive airway diseases and a proprietary platform, CIL-Key™, for the delivery of RNA-based therapeutics and vaccines.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CILA Therapeutics Comps
Public and private peers based on sector, stage, and business model.
CILA Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 11, 2025 |
CILA Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| National Center for Advancing Translational Sciences | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 23, 2026
Monthly visitors increased 91% MoM.
- Jan 7, 2026
Monthly visitors grew 326% MoM, from 399 to 1.7K.
CILA Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CILA Therapeutics's valuation, stock price, and market status.
